Limnospira platensis decreases triglycerides

lowersModerate evidenceFindingreplicated ×4

01 · The sentence it was drawn from

“Mean triglycerides levels were significantly decreased in the Spirulysat® group compared to placebo at V3 (1.23 ± 0.57 vs. 1.97 ± 0.80 g/L, p = 0.003).”

Quoted verbatim from Antioxidant Efficacy of a Spirulina Liquid Extract on Oxidative Stress Status and Metabolic Disturbances in Subjects with Metabolic Syndrome.

This finding among the 108 findings on its endpoint

Limnospira platensis

Triglycerides

lowers

Who: Adults aged 18-65 with metabolic syndrome and BMI 25-35; Spirulysat versus placebo of identical appearance and packaging; end-of-study visit V3 (12 weeks)
Dose studied: 2 vials of 10 mL per day before breakfast, 12 weeks; the paper states a low dose of about 20 mg per day (2 x 10 mg)

Moderate evidencePMID 35877734 · 2022

02 · The study

Study: RCT
Duration: 3 months

Evidence, by strength

strong
moderatethis finding
limited
very limited
insufficient

03 · The paper

Marine drugs

Antioxidant Efficacy of a Spirulina Liquid Extract on Oxidative Stress Status and Metabolic Disturbances in Subjects with Metabolic Syndrome.

2022PMID 35877734doi 10.3390/md20070441Industry funded

What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M71MKRER3609YG63Y90444YH